2.A case of transcaval transcatheter aortic valve replacement.
Zhen Gang ZHAO ; Zhong Kai ZHU ; Yong PENG ; Jia Fu WEI ; Sen HE ; Yong CHEN ; Xuan ZHOU ; Xin WEI ; Ming Xia ZHENG ; Guo CHEN ; Wei MENG ; Bin HUANG ; Yuan FENG ; Mao CHEN
Chinese Journal of Cardiology 2022;50(3):292-294
3.Transcatheter Aortic Valve Implantation in a Patient with Previous Mitral Valve Replacement.
Sung Woo MOON ; Young Guk KO ; Geu Ru HONG ; Sak LEE ; Byung Chul CHANG ; Jae Kwang SHIM ; Young Ran KWAK ; Myeong Ki HONG
Korean Circulation Journal 2014;44(5):344-347
Transcatheter aortic valve implantation (TAVI) has shown favorable outcomes in patients with severe symptomatic aortic valve stenosis who are at high surgical risk or are unsuitable candidates for open heart surgery. However, concerns exist over treating patients who have previously undergone mitral valve surgery due to the potential interference between the mitral prosthetic valve or ring and the TAVI device. In this case report, we present a patient with symptomatic severe aortic stenosis and previous mechanical mitral valve replacement who was successfully treated with TAVI using a CoreValve.
Aortic Valve Stenosis
;
Aortic Valve*
;
Catheters
;
Heart Valve Prosthesis
;
Humans
;
Mitral Valve*
;
Prosthesis Implantation
;
Thoracic Surgery
6.Transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis: a meta analysis.
Yi-Cheng WU ; Jian-Feng ZHANG ; Wei-Feng SHEN ; Qiang ZHAO
Chinese Medical Journal 2013;126(6):1171-1177
BACKGROUNDTranscatheter aortic valve implantation (TAVI) has emerged as the treatment choice for non-operable patients with severe symptomatic aortic stenosis (AS) and may be a good alternative to surgery for those at very high or prohibitive surgical risk. We performed a meta-analysis to evaluate the comparative benefits of TAVI versus surgical aortic valve replacement (SAVR) in patients with severe AS.
METHODSA comprehensive literature search of PubMed, Embase, ScienceDirect and Cochrane Central Register of Controlled trials was performed, and randomized trials as well as cohort studies with propensity score analysis were included.
RESULTSOne randomized trial (n = 699) and six retrospective cohort studies (n = 781) were selected for meta-analysis. Mortality at 30-day and 1-year follow-up was comparable between TAVI and SAVR. Despite similar incidences of stroke, myocardial infarction, re-operation for bleeding, and renal failure requiring dialysis, TAVI was associated with a lower occurrence rate of new-onset atrial fibrillation (OR 0.51, 95%CI 0.33 - 0.78) and shorter procedural time (mean difference -67.50 minutes, 95%CI -87.20 to -47.81 minutes). Post-operative aortic regurgitation and permanent pacemaker implantation were more common in patients after TAVI than in those with SAVR (OR 5.53, 95%CI 3.41 - 8.97; OR 1.71, 95%CI 1.02 - 2.84, respectively).
CONCLUSIONIn patients with severe symptomatic AS, TAVI and SAVR did not differ with respect to short- and mid-term survival, but the incidence of permanent pacemaker implantation and post-procedural aortic regurgitation remain relatively high after TAVI.
Aortic Valve Stenosis ; surgery ; therapy ; Heart Valve Prosthesis ; Humans
7.Simultaneous transcatheter aortic valve replacement and mitral balloon dilatation in patients with severe aortic stenosis and mitral stenosis: two case reports.
Hao Jian DONG ; Rui WANG ; Xia WANG ; Jian LIU ; Bu Zha Xi PU ; Jie LI ; Yu Jing MO ; Ming FU ; Guang LI ; Jian Fang LUO
Chinese Journal of Cardiology 2023;51(10):1082-1086
8.Simultaneous transcatheter aortic valve replacement and mitral balloon dilatation in patients with severe aortic stenosis and mitral stenosis: two case reports.
Hao Jian DONG ; Rui WANG ; Xia WANG ; Jian LIU ; Bu Zha Xi PU ; Jie LI ; Yu Jing MO ; Ming FU ; Guang LI ; Jian Fang LUO
Chinese Journal of Cardiology 2023;51(10):1082-1086
Result Analysis
Print
Save
E-mail